A New Standard In Thrombectomy
– Centers and secures the catheter tip position within the vessel using SafeSeal™ Technology
– Proximally occludes antegrade blood flow from the target work zone creating a static work environment
– Has the ability to deliver lesion disruptive devices and other therapeutic devices through the .060” ID lumen
– Provides strong aspiration via VacLok® syringes, the large-mouth funnel, and SafeSeal™ Technology
– Removes thrombus and emboli throughout the peripheral and coronary vasculature
A distinctive feature of the MegaVac™ System is its ability to safely seal the target work zone, proximally occluding antegrade blood flow, thereby reducing the potential for an embolic occurrence while performing these highly disruptive treatments. In addition the MegaVac™ System allows physicians to work continuously without blood flow interference.
The MegaVac™ System was designed to be used not only as a standalone thrombectomy system, but also to be used in coordination with other peripheral treatments as a device-delivery-system without the need for cumbersome and expensive capital equipment. Minimizing catheter exchanges, the MegaVac™ System can serve as a conduit for delivering devices such as atherectomy systems, CTO crossing wires, balloons, stents as well as the ThromboWire™ Clot Retractor.
Notable to the MegaVac™ System, the MegaVac™ Catheter with SafeSeal™ Technology creates a wide-mouth channel to address problematic lesions. The large 0.060” ID lumen is a smooth conduit for the delivery of fluids as well as the removal of emboli and thrombotic material via aspiration and deployment of the ThromboWire™ embolectomy element. The MegaVac™ System is optimized for the retrieval of embolic and thrombotic materials.
The MegaVac™ Catheter with SafeSeal™ Technology provides simple on/off proximal occlusion of antegrade blood flow. The funnel tip, when deployed, opens slightly and then uses the patient’s own blood pressure to fully deploy and safely press the silicone coated occlusion funnel to the vessel wall.
Balloons tend to exceed the optimal occlusion pressure as there is no known endpoint for occlusion other than injecting contrast into the vessel (a trial and error approach), hence often times balloons are inflated beyond the optimal sealing pressure to ensure a seal.
With negligible outward radial force there is a lower potential to damage the vessel. Histological sections have shown the MegaVac™ Catheter with SafeSeal™ Technology does not leave any visible evidence that it has been deployed.